HI
MYGN icon

Hendershot Investments’s Myriad Genetics MYGN Stock Holding History

Hendershot Investments’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-61,360
Closed -$2.09M – 62
2015
Q2 		$2.09M Sell
61,360
-90
-0.1% -$3.06K 1.09% 37
2015
Q1 		$2.17M Sell
61,450
-815
-1% -$29.2K 1.15% 37
2014
Q4 		$2.12M Hold
62,265
– – 1.11% 35
2014
Q3 		$2.4M Sell
62,265
-2,180
-3% -$81.3K 1.35% 32
2014
Q2 		$2.51M Sell
64,445
-250
-0.4% -$9.3K 1.48% 30
2014
Q1 		$2.21M Sell
64,695
-3,125
-5% -$96.8K 1.36% 30
2013
Q4 		$1.42M Buy
+67,820
New +$1.72M 0.92% 39

Other funds holding MYGN

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Hendershot Investments's MYGN Position: Q3 2015 in Review

Hendershot Investments sold out of Myriad Genetics (MYGN) in Q3 2015, closing a stake of 61,360 shares — an estimated $2.09M sold.

Hendershot Investments first reported a position in MYGN in Q4 2013 and held it in 7 quarters. The position peaked at $2.51M in Q2 2014. 234 funds tracked by Wall St. Rank hold MYGN as of Q3 2015.

  • Hendershot Investments reported no remaining Myriad Genetics position as of Q3 2015 after selling out during the quarter.
  • Hendershot Investments sold 61,360 Myriad Genetics shares in Q3 2015, an estimated $2.09M.
  • Hendershot Investments first reported a position in Myriad Genetics in Q4 2013 and held it in 7 quarters.
  • Hendershot Investments's Myriad Genetics position peaked at $2.51M in Q2 2014.
  • 234 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2015.

Based on Hendershot Investments's 13F filing for Q3 2015, filed 6 Nov 2015.